These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1503083)

  • 41. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator.
    Takahashi H; Ito S; Hanano M; Wada K; Niwano H; Seki Y; Shibata A
    Am J Hematol; 1992 Sep; 41(1):32-9. PubMed ID: 1323930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in von Willebrand factor and fibrinolysis following a post-exercise cool-down.
    Paton CM; Nagelkirk PR; Coughlin AM; Cooper JA; Davis GA; Hassouna H; Pivarnik JM; Womack CJ
    Eur J Appl Physiol; 2004 Jul; 92(3):328-33. PubMed ID: 15098129
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT).
    Seeber C; Hiller E; Holler E; Kolb HJ
    Thromb Res; 1992 May; 66(4):373-83. PubMed ID: 1412203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Activation of endothelium-dependent hemostatic factors following bone marrow transplantation].
    Tsakiris DA; Marbet GA; Tichelli A; Gratwohl A; Speck B
    Schweiz Med Wochenschr; 1995 Mar; 125(9):416-9. PubMed ID: 7892569
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
    Iványi JL; Marton E; Plander M
    Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An endothelial storage granule for tissue-type plasminogen activator.
    Emeis JJ; van den Eijnden-Schrauwen Y; van den Hoogen CM; de Priester W; Westmuckett A; Lupu F
    J Cell Biol; 1997 Oct; 139(1):245-56. PubMed ID: 9314543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired fibrinolytic capacity in patients with inflammatory bowel disease.
    Gris JC; Schved JF; Raffanel C; Dubois A; Aguilar-Martinez P; Arnaud A; Sanchez N; Sarlat C; Balmès JL
    Thromb Haemost; 1990 Jun; 63(3):472-5. PubMed ID: 2119529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraplatelet levels of vWF:Ag and fibrinogen in myeloproliferative disorders.
    Meschengieser S; Blanco A; Woods A; Maugeri N; Fernandez J; Dupont J; Lazzari MA
    Thromb Res; 1987 Nov; 48(3):311-9. PubMed ID: 3501618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Selected parameters of hemostasis in patients with myeloproliferative neoplasms.
    Gadomska G; Rość D; Stankowska K; Boinska J; Ruszkowska-Ciastek B; Wieczór R
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):464-70. PubMed ID: 24509338
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of carvedilol or metoprolol on PAI-1, tPA-mass concentration or Von Willebrand factor in chronic heart failure--a COMET substudy.
    Boman K; Jansson JH; Nilsson T; Swedberg K; Cleland JG; Poole-Wilson P
    Thromb Res; 2010 Feb; 125(2):e46-50. PubMed ID: 19762071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
    Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Local variation in expression of pro- and antithrombotic factors in vascular endothelium of human autopsy brain.
    Tohgi H; Utsugisawa K; Yoshimura M; Nagane Y; Ukitsu M
    Acta Neuropathol; 1999 Aug; 98(2):111-8. PubMed ID: 10442549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers.
    Casonato A; Pontara E; Dannhäuser D; Bertomoro A; Sartori MT; Girolami A
    Haematologia (Budap); 1994; 26(2):97-109. PubMed ID: 7890268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J; Lillicrap DP; Izaguirre CA; Sutherland M; Windsor S; Benford K; Hoogendorn H; Giles AR
    Am J Clin Pathol; 1989 Oct; 92(4):471-8. PubMed ID: 2508465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perturbed (procoagulant) endothelium and deviations within the fibrinolytic system during the third trimester of normal pregnancy. A possible link to placental function.
    Sørensen JD; Secher NJ; Jespersen J
    Acta Obstet Gynecol Scand; 1995 Apr; 74(4):257-61. PubMed ID: 7732797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clot lysis mediated by cultured human microvascular endothelial cells.
    Speiser W; Anders E; Binder BR; Müller-Berghaus G
    Thromb Haemost; 1988 Dec; 60(3):463-7. PubMed ID: 3149047
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
    Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
    J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are increased levels of von Willebrand factor in chronic coronary heart disease caused by decrease in von Willebrand factor cleaving protease activity? A study by an immunoassay with antibody against intact bond 842Tyr-843Met of the von Willebrand factor protein.
    He S; Cao H; Magnusson CG; Eriksson-Berg M; Mehrkash M; Schenck-Gustafsson K; Blombäck M
    Thromb Res; 2001 Aug; 103(3):241-8. PubMed ID: 11672586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.
    Jansson JH; Nilsson TK; Johnson O
    Heart; 1998 Oct; 80(4):334-7. PubMed ID: 9875107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.